CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 23 filers reported holding CERULEAN PHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,018,000 | -20.4% | 551,354 | 0.0% | 0.32% | -4.5% |
| Q2 2015 | $2,536,000 | -29.9% | 551,354 | +37.4% | 0.34% | -39.7% |
| Q1 2015 | $3,616,000 | +29.2% | 401,354 | -10.8% | 0.56% | +29.4% |
| Q4 2014 | $2,799,000 | +47.4% | 450,000 | 0.0% | 0.43% | +10.5% |
| Q3 2014 | $1,899,000 | -27.2% | 450,000 | 0.0% | 0.39% | -43.5% |
| Q2 2014 | $2,610,000 | – | 450,000 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $6,970,000 | 7.48% |
| Polaris Venture Management Co IV LLC | 1,437,441 | $3,047,000 | 5.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $954,000 | 0.25% |
| Deer VII & Co. Ltd. | 166,675 | $353,000 | 0.16% |
| Rock Springs Capital Management LP | 625,000 | $1,325,000 | 0.10% |
| Granahan Investment Management | 708,215 | $1,501,000 | 0.06% |
| Northeast Financial Consultants Inc | 20,000 | $42,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 202,623 | $430,000 | 0.01% |
| WEDBUSH SECURITIES INC | 16,000 | $34,000 | 0.01% |
| Alyeska Investment Group, L.P. | 319,289 | $677,000 | 0.01% |